Fda Alerts Article Listing | RxWiki

FDA Alerts

FDA approves Simponi

The U.S. Food and Drug Administration today approved a new use for Simponi (golimumab) injection to treat adults with moderate to severe ulcerative colitis.

REFINE

medications
- - Remove Simponi filter (-) Remove Simponi filter Simponi
conditions
- - Apply Gastrointestinal filter Gastrointestinal (1) Apply Gastrointestinal filter
    Apply Ulcerative Colitis filter Ulcerative Colitis (1) Apply Ulcerative Colitis filter